In addition, ATG4B overexpression conferred cancer drug resistance while its inhibition markedly sensitized tumors to chemotherapy in lung cancer [22], colon cancer [23], and chronic myeloid leukemia [24]. Here, ATG4B is linked to colonic neoplasm.